Article

The Spokesman-Review on 2018-12-03 19:45

GlaxoSmithKline to spend $5.1B on cancer drugmaker Tesaro - Mon, 03 Dec 2018 PST

Shares of Tesaro soared Monday after GlaxoSmithKline said it would pay about $5.1 billion in cash to buy the cancer drugmaker.

Related news

GlaxoSmithKline to spend $5.1B on cancer drugmaker Tesaro neworleanscitybusiness.com
Waltham
Waltham's Tesaro to be acquired by GlaxoSmithKline for $5.1B bizjournals.com
Waltham
GlaxoSmithKline acquiring Tesaro for $5.1B bizjournals.com
NGSK buying cancer drugmaker Tesaro in $5.1 billion deal nypost.com
United Kingdom
GlaxoSmithKline to Acquire Tesaro for $4.16 Billion wsj.com
Latest drug by Waltham drugmaker Tesaro rejected by FDA bizjournals.com
Waltham
WGSK acquiring oncology firm Tesaro in $5.1B deal, sells health drinks for $3.7B wraltechwire.com
Zebulon , Bangladesh , India
LCINV Existing and Pipeline Drugs Market 2021 Outlook, Demand, Regional Analysis, Industry Value Chain | Operating Vendors: GlaxoSmithKline, Merck, Helsinn, Heron Therapeutics, Tesaro…liverpoolstudentmedia.com
Africa , Middle East , Mexico , Brazil , Latin America
GlaxoSmithKline snaps up 10% stake in Covid-19 drugmaker bizjournals.com
GlaxoSmithKline beats forecasts on weak-pound windfall The Globe and Mail
China , United Kingdom
GlaxoSmithKline names insider Emma Walmsley as its new CEO timesofmalta.com
Switzerland , China , United Kingdom
GlaxoSmithKline Names CEO wsj.com
FGlaxoSmithKline: Out of step ft.com
Beijing , Brazil , China , Middle East
U.S. To Spend $2.1 Billion On GlaxoSmithKline-Sanofi Covid-19 Vaccine Forbes
Drugmaker AbbVie to spend over $10 billion on ImmunoGen to juice its cancer-fighting treatment portfolio pressherald.com
North Chicago , Massachusetts , Waltham
TGlaxoSmithKline receives boost in China thisismoney.co.uk
Switzerland , China
GSK Buys Tesaro For $5 Billion In Dramatic Bet On Cancer Genetics Forbes
Clovis